A 37-year-old woman with a coronary thrombosis was transferred to the obstetric ward because she was in the 33rd week of pregnancy. The thrombosis was indicated by a creatine phosphokinase MB fraction of 38 ng/mL, along with an ST-segment elevation in leads V1 through V3 on the electrocardiogram.We detected the blockage of a thin anterior interventricular artery on coronography, which was immediately performed, and ventriculography revealed important anteroapical akinesia. Following a right interventricular transluminal angioplasty, the patient was treated with 200 mg per day of metoprolol, 20 mg of furosemide twice per day, and 160 mg per day of salicylic acid, and remained stable. The maximal concentration of creatine phosphokinase was measured 7 hours after treatment initiation. Corticosteroid therapy was initiated for lung maturation even though the fetal signs were reassuring.The findings of a clinical examination were all within normal limits a week later, but a control electrocardiogram showed a Q wave infarction and a control echocardiography showed a small anteroapical area of akinesia. The ejection fraction of the left ventricle was 40%. The remainder of the pregnancy was uneventful, with satisfactory maternal and fetal vitality, and vaginal delivery was allowed. The patient gave birth at 36 weeks to a female neonate weighing 2700 g with an Apgar score of 10 at 5 minutes. She returned home 10 days postpartum with the same pharmacologic treatment.Coronary thrombosis can arise at any age and in all phases of pregnancy, but mostly during the third trimester. The coronary affection frequently affects only 1 vessel. Most maternal deaths arise at the time of infarction or in the 2 weeks following infarction, which often coincide with delivery. Fetal death in utero is often concomitant with maternal death, and maternal and fetal mortality from maternal myocardial infarction is 35% and 34%, respectively [1].Diagnosis is generally delayed in pregnant women because of a low threshold of suspicion for myocardial infarction during pregnancy, even though the clinical signs are the same for pregnant women and the general population. Once myocardial infarction has been evoked as a possibility, diagnosis is confirmed by an electrocardiogram, the measurement of myocardial necrosis enzymes, and magnetic resonance imaging [2]. As a rule, pregnancy does not affect the diagnostic and therapeutic plans.In cases of arterial obstruction, early reperfusion by transluminal coronary angioplasty is the preferred option because it has fewer contraindications than thrombolysis [3]. The choice between angioplasty and thrombolysis will depend on team experience, time since the infarction, extent and severity of the infarct, and pregnancy duration.The remainder of the pregnancy is most often uneventful, with normal fetal development, which makes a cesarean delivery unwarranted in most cases. Outside of obstetric indications, a cesarean delivery is necessary in women with an unstable cardiac function or a hemorrhagic syndrome [4].Women ...
This study aims to model the groundwater storage areas in the Guigou basin using Geographic Information System (GIS), Remote Sensing (RS) and AHP methods. Eight thematic maps of lithology, slope, rainfall, rock fracture, Fractional impervious surfaces, LU/LC, soil and drainage were respectively classified and weighted and then used to create the map of potential groundwater storage areas. The results have shown that the area of Medium, high, and very high potential zones make up 66.38%, 11.43%, and 0.048% of the total, respectively, while medium and low potential zones make up 22.14% and 0.002% of the total. The obtained results have been validated with 51 wells in the study area. It indicates a clear correlation between the groundwater potential zones and the wells depth, This relationship between depth and location of drilled wells is particularly clear; in fact, the majority of shallow wells are found in places with high potential, whilst the majority of deep wells are found in areas with low potential.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.